Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Business Perspectives in The Oncology Arena - Optimizing Deal Values NOT LIVE' returned 3 results - Page 1 of 1  FEATURED RESULTS Cancer Diagnostic Testing World Markets Drug Delivery in Cancer - Technologies, Markets and Companies Antibody Drug Target Atlas in Oncology Oncology Review and Outlook 2010 Challenges in Oncology Clinical Trial Design   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Biopharma Quarter: Key Trends and Events of the First Quarter of 2009   Decision Resources, Inc., June 2009, Pages: 47 On the Approvals Front: FDA’s First “Pharm” Animal Drug Approval Deals Perspective Mergers & Acquisitions Notable Product-Related Deals Therapy-Area Deals—Focus on Oncology Biologics Continue to Be a Dealmaking Biomarkers - Global Strategic Business Report   Global Industry Analysts, Inc., Aug 2011, Pages: 1305 : An Insight 13 Table 4: Growing Number of Biomarker Deals (includes corresponding Graph/Chart) 13 Table 5: Competitive Strategy Mix in the Global Oncology Biomarkers Market (includes corresponding Graph Molecular Diagnostics - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2010, Pages: 659 : Worldwide Molecular Diagnostics Market by Leading Players (2006 - A Recent Past Perspective) - Market Share Breakdown by Value Sales for Roche Diagnostics, Chiron, Bayer Diagnostics, GenProbe, Abbott Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network